Characterization of neurotropic HPAI H5N1 viruses with novel genome constellations and mammalian adaptive mutations in free-living mesocarnivores in Canada.
Clade 2.3.4.4b
H5N1
HPAI
mammals
mutation
reassortment
Journal
Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
pubmed:
8
3
2023
medline:
17
3
2023
entrez:
7
3
2023
Statut:
ppublish
Résumé
The GsGd lineage (A/goose/Guangdong/1/1996) H5N1 virus was introduced to Canada in 2021/2022 through the Atlantic and East Asia-Australasia/Pacific flyways by migratory birds. This was followed by unprecedented outbreaks affecting domestic and wild birds, with spillover into other animals. Here, we report sporadic cases of H5N1 in 40 free-living mesocarnivore species such as red foxes, striped skunks, and mink in Canada. The clinical presentations of the disease in mesocarnivores were consistent with central nervous system infection. This was supported by the presence of microscopic lesions and the presence of abundant IAV antigen by immunohistochemistry. Some red foxes that survived clinical infection developed anti-H5N1 antibodies. Phylogenetically, the H5N1 viruses from the mesocarnivore species belonged to clade 2.3.4.4b and had four different genome constellation patterns. The first group of viruses had wholly Eurasian (EA) genome segments. The other three groups were reassortant viruses containing genome segments derived from both North American (NAm) and EA influenza A viruses. Almost 17 percent of the H5N1 viruses had mammalian adaptive mutations (E627 K, E627V and D701N) in the polymerase basic protein 2 (PB2) subunit of the RNA polymerase complex. Other mutations that may favour adaptation to mammalian hosts were also present in other internal gene segments. The detection of these critical mutations in a large number of mammals within short duration after virus introduction inevitably highlights the need for continually monitoring and assessing mammalian-origin H5N1 clade 2.3.4.4b viruses for adaptive mutations, which potentially can facilitate virus replication, horizontal transmission and posing pandemic risks for humans.
Identifiants
pubmed: 36880345
doi: 10.1080/22221751.2023.2186608
pmc: PMC10026807
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2186608Références
Arch Virol. 1994;135(1-2):101-14
pubmed: 8198436
Emerg Infect Dis. 2018 Dec;24(12):2343-2347
pubmed: 30457524
PLoS Comput Biol. 2019 Apr 8;15(4):e1006650
pubmed: 30958812
J Virol. 2015 Dec 09;90(4):1872-9
pubmed: 26656683
J Virol. 1997 Aug;71(8):6128-35
pubmed: 9223507
Sci Rep. 2016 May 10;6:25845
pubmed: 27162026
Virology. 1972 Mar;47(3):579-91
pubmed: 5062472
J Virol. 2015 Jun;89(12):6521-4
pubmed: 25855748
PLoS Pathog. 2019 Jul 2;15(7):e1007919
pubmed: 31265471
PLoS Pathog. 2008 Feb 8;4(2):e11
pubmed: 18248089
J Virol. 2016 Jun 24;90(14):6235-6243
pubmed: 27122581
J Virol. 2015 Oct;89(19):9939-51
pubmed: 26202239
J Am Chem Soc. 2015 Dec 9;137(48):15122-34
pubmed: 26424125
Virus Res. 2013 Dec 5;178(1):53-62
pubmed: 23732876
Cell Host Microbe. 2015 Mar 11;17(3):309-319
pubmed: 25704008
Emerg Microbes Infect. 2022 Dec;11(1):725-729
pubmed: 35172704
Virus Evol. 2019 Apr 22;5(1):vez004
pubmed: 31024736
Emerg Infect Dis. 2021 Nov;27(11):2856-2863
pubmed: 34670647
Emerg Infect Dis. 2018 Apr;24(4):746-750
pubmed: 29553313
J Virol. 2010 Mar;84(5):2245-56
pubmed: 20015998
Emerg Infect Dis. 2008 Dec;14(12):1835-41
pubmed: 19046504
Virology. 2017 Sep;509:159-166
pubmed: 28646651
J Virol. 2010 May;84(9):4395-406
pubmed: 20181719
Sci Rep. 2016 Nov 04;6:36237
pubmed: 27812044
Proc Natl Acad Sci U S A. 1976 Sep;73(9):3045-9
pubmed: 1067600
J Virol. 2014 Mar;88(6):3127-34
pubmed: 24371069
Virology. 1999 Aug 15;261(1):15-9
pubmed: 10484749
J Virol. 2011 Sep;85(17):8718-24
pubmed: 21734057
J Virol Methods. 2008 Feb;147(2):265-74
pubmed: 18006085
PLoS Pathog. 2009 Jan;5(1):e1000252
pubmed: 19119420
J Virol. 2014 Mar;88(6):3568-76
pubmed: 24403592
Emerg Infect Dis. 2004 Dec;10(12):2189-91
pubmed: 15663858
Innovation (Camb). 2021 Jan 21;2(1):100084
pubmed: 34557739
J Clin Microbiol. 2002 Sep;40(9):3256-60
pubmed: 12202562
Vaccine. 2008 Sep 12;26 Suppl 4:D49-53
pubmed: 19230160
Nat Commun. 2015 Jun 17;6:7491
pubmed: 26082035
Sci Rep. 2022 Jul 11;12(1):11729
pubmed: 35821511
Vet Microbiol. 2017 Mar;201:225-230
pubmed: 28284614
Emerg Infect Dis. 2006 Nov;12(11):1744-7
pubmed: 17283627
PLoS One. 2008;3(12):e3904
pubmed: 19066626
J Biol Chem. 2011 Mar 25;286(12):10439-48
pubmed: 21216958
J Virol Methods. 2009 Dec;162(1-2):194-202
pubmed: 19699764
Genetics. 2002 Jul;161(3):1307-20
pubmed: 12136032
Emerg Infect Dis. 2021 Nov;27(11):2960-2962
pubmed: 34670656
Emerg Infect Dis. 2016 Jul;22(7):1283-5
pubmed: 27314845
J Virol. 2010 Jul;84(13):6825-33
pubmed: 20392847
Sci Rep. 2015 Mar 25;5:9484
pubmed: 25804829
J Gen Virol. 2017 Jan;98(1):6-17
pubmed: 27926816
Virus Res. 2009 Sep;144(1-2):123-9
pubmed: 19393699
Virus Evol. 2022 Aug 25;8(2):veac077
pubmed: 36105667
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2845-50
pubmed: 16473931
Philos Trans R Soc Lond B Biol Sci. 2019 Jun 24;374(1775):20180257
pubmed: 31056053
Vet Pathol. 2007 May;44(3):261-8
pubmed: 17491066
Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23807-23814
pubmed: 32873642
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18590-5
pubmed: 16339318
mSphere. 2018 Jan 3;3(1):
pubmed: 29299528
J Biol Chem. 2011 Oct 7;286(40):34504-13
pubmed: 21816827
Science. 2001 Sep 7;293(5536):1840-2
pubmed: 11546875